Position in GNTA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$241,920
-$294,480 QoQ
Shares Held
360,000
0.0% QoQ
Ownership
0.747%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GNTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Eurizon Capital SGR S.p.A. holds $100,991,251 across 37 Biotechnology names. GNTA ranks #15 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,509 | $36,397,028 | |
| 2 | INCY |
Incyte Corp
|
210,792 | $19,839,743 | |
| 3 | RPRX |
Royalty Pharma plc
|
318,411 | $15,274,175 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,525 | $12,767,876 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,184 | $8,001,760 | |
| 6 | INSM |
INSMED Inc
|
18,473 | $3,020,704 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
11,152 | $629,976 | |
| 8 | MRNA |
Moderna, Inc.
|
8,104 | $411,683 |
All Filings in GNTA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $241,920 | 360,000 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $536,400 | 360,000 | Shares | Other | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||